Saama and Comprehend to Form Preeminent Clinical Analytics Platform Company

Transaction Creates Expanded Portfolio of Cloud-Based Capabilities to Advance Clinical Development
Saama Logo

Campbell, CA (August 13, 2019) - Saama Technologies, Inc. (“Saama”) announced today that it has signed a definitive agreement to acquire Comprehend Systems, Inc. (“Comprehend”). This agreement combines Saama and Comprehend’s respective industry positions as leading clinical data analytics companies. Together, Saama and Comprehend will deploy and evolve their complementary, best-in-class clinical analytics platforms. This agreement creates an opportunity to increase their combined market share, as well as expand their existing partner ecosystems and deliver on a mutual commitment to accelerate clinical development towards unmet patient needs.

“Our combined forces create an exciting, enhanced suite of complementary capabilities to empower life sciences companies to further accelerate clinical development and meet the therapeutic needs of patients around the world, challenge the status quo, and achieve clinical insights in days versus months,” said Suresh Katta, Founder and Chairman of Saama. “Combining Saama and Comprehend elevates our ability to do what we do best – innovate cutting-edge, AI-powered clinical development solutions and software that empower biopharma to facilitate more rapid drug development.”

“The Comprehend-Saama transaction creates a data analytics powerhouse with a singular vision of improving human health through the application of AI-powered solutions for actionable clinical trial insights,” said Rick Morrison, Founder and Chairman of Comprehend. "The combined 30-plus years of experience of these two companies as data analytics innovators provides exciting opportunities to speed biopharma’s development of new therapeutics and to have broader industry reach.”

“Saama and Comprehend offer life sciences companies and patient-focused organizations the ability to access and optimize a combined ecosystem of unique, state-of-the-art analytics solutions and visualization tools that enable the re-imagination of clinical development and the realization of precision medicine,” said Rebecca Daniels Kush, Ph.D., founder of the Clinical Data Interchange Standards Consortium (CDISC), and member of Saama’s Clinical Board of Advisors.

About Saama Technologies, Inc.

Saama Technologies is the advanced clinical data and analytics company, unleashing wisdom from data to deliver better actionable business outcomes for the life sciences industry. Saama’s unified, AI-driven clinical data analytics cloud platform seamlessly integrates, curates, and animates unlimited sources of structured, unstructured, and real-world data to deliver actionable insights across all therapeutic areas. The award-winning platform gives unprecedented real-time visibility into clinical data, enabling sponsors to file New Drug Applications (NDAs) more efficiently to bring drugs to market faster and at lower costs. For more information, visit https://www.saama.com.

About Comprehend

Comprehend provides a suite of cloud applications and consulting services that dramatically improve the clinical trial process. Our solutions deliver actionable risk and performance insights across studies, systems, sites, and vendors. By using elements of our Clinical Intelligence Platform to unify, monitor, and analyze data across all sources, sponsors and CROs alike are able to reduce risk, achieve milestones on time, and stay within budget. As a trusted partner, Comprehend helps speed the time to quality results. For more information, visit https://www.comprehend.com.

About Carrick Capital Partners
Who We Are
A firm of enterprise software, SaaS, and technology enabled services investors and operating executives with substantial experience founding, scaling, and optimizing market leading businesses.
Our Approach
We work with management to identify and improve critical areas of their business - focusing on the priorities that align with our experiences and that will deliver the highest strategic impact in both the short-term and long-run.
Why We Are Different
We have a concentrated number of companies in our portfolio so that we can build substantial relationships with each management team and ensure our firm's commitment to each company's goals.
Latest News
Carrick Logo TM.jpg
LOS GATOS, CA (October 20, 2020) – Neeyamo Inc. is pleased to announce that Jim Madden, Co-Founder and Managing Director of Carrick Capital Partners will deliver the opening keynote at Rise Above 2020, a virtual global HR Evolution Summit taking place November 12th and 13th. Hosted by Neeyamo along with a cohort of global industry associations, the event will feature more than 50 speakers representing various avenues in the HR & payroll arena who will share their experiential insights to set a resilient HR agenda for 2021 and beyond. View the detailed event agenda here.
October 20, 2020
Accolade Logo.jpg
SEATTLE, WA (October 14, 2020) - Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced financial results for the fiscal second quarter ended August 31, 2020.
October 15, 2020
Exiger Logo.jpg
NEW YORK, WASHINGTON, D.C., LONDON and SYDNEY (October 14, 2020) - Exiger, Exiger, the GRC firm transforming the global fight against financial crime and fraud, is investing to expand Exiger Intelligence, an industry-first delivery model combining award-winning technology, practical expertise and analytics-led process to address the growing challenge of managing today's data-heavy regulatory compliance enforcement, government investigations, and complex litigation environment. From eDiscovery and litigation support to compliance and risk analytics, Exiger Intelligence ushers in the next-generation of data-driven investigations and sustainable risk management solutions.
October 14, 2020